PHAR
Pharming Group N.V.
NASDAQ · Healthcare · Biotechnology · NL
$11.23
−2.01%Leverage
- Debt / equity
- 0.42x
- Net debt / equity
- -0.17x
- Debt / assets
- 0.24x
- Debt / EBITDA
- 2.66x
- Net debt / EBITDA
- -1.05x
Liquidity & coverage
- Current ratio
- 3.01x
- Quick ratio
- 2.31x
- Cash ratio
- 1.70x
- Interest coverage
- 0.84x
- EBITDA / interest
- 2.90x
- Working capital
- $187.4M
Cash & dividend
- FCF / debt
- 0.28x
- Cash flow / debt
- 0.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026